Arizona State Retirement System’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,610
Closed -$223K 2108
2024
Q1
$223K Sell
6,610
-83
-1% -$2.94K ﹤0.01% 1873
2023
Q4
$211K Buy
+6,693
New +$159K ﹤0.01% 1921
2022
Q1
Sell
-5,669
Closed -$210K 2238
2021
Q4
$210K Sell
5,669
-67
-1% -$2.73K ﹤0.01% 2060
2021
Q3
$274K Buy
+5,736
New +$257K ﹤0.01% 1895
2021
Q2
Sell
-5,704
Closed -$236K 2226
2021
Q1
$236K Buy
5,704
+46
+0.8% +$2.74K ﹤0.01% 1945
2020
Q4
$245K Sell
5,658
-104
-2% -$7.04K ﹤0.01% 1841
2020
Q3
$247K Buy
+5,762
New +$286K ﹤0.01% 1686

Other funds holding ARCT

Arizona State Retirement System's ARCT Position: Q2 2024 in Review

Arizona State Retirement System sold out of Arcturus Therapeutics (ARCT) in Q2 2024, closing a stake of 6,610 shares — an estimated $223K sold.

Arizona State Retirement System first reported a position in ARCT in Q3 2020 and held it in 7 quarters. The position peaked at $274K in Q3 2021. 171 funds tracked by Wall St. Rank hold ARCT as of Q2 2024.

  • Arizona State Retirement System reported no remaining Arcturus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 6,610 Arcturus Therapeutics shares in Q2 2024, an estimated $223K.
  • Arizona State Retirement System first reported a position in Arcturus Therapeutics in Q3 2020 and held it in 7 quarters.
  • Arizona State Retirement System's Arcturus Therapeutics position peaked at $274K in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2024.

Based on Arizona State Retirement System's 13F filing for Q2 2024, filed 5 Aug 2024.